[{"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0511-2018", "product_description": "Naltrexone HCl USP (Dihydrate) for prescription compounding, packaged in a) 1g (NDC 58597-8407-1); b) 5g (NDC 58597-8407-2); c) 25g (NDC 58597-8407-4); d) 100g (NDC 58597-8407-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "7000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a)  120916-1, Exp. 10/31/2019;  b) 120916-1, Exp. 10/31/2019  c) 120916-1, Exp. 10/31/2019; d) 120916-1, Exp. 10/31/2019."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0205-2018", "product_description": "Vitamin 10 B Lyophilized Vial, For IM Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "5786 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots; 05232017@13 BUD: 11/19/2017; 05262017@2 BUD: 11/22/2017; 06022017@1 BUD: 11/29/2017; 06092017@1 BUD: 12/6/2017; 06162017@10 BUD: 12/13/2017; 08142017@10 BUD: 2/10/2018; 08252017@1 BUD: 2/21/2018; 09222017@1 BUD: 3/21/2018; 09292017@1 BUD: 3/28/2018; 10062017@1 BUD: 4/4/2018; 10132017@2 BUD: 4/11/2018", "more_code_info": ""}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "100 bags", "code_info": "Lot # 5/1/18 0501 548-90510P, BUD 7/30/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "MAGnesium 4gm in NS 100 mL (MAGnesium SULfate (USP) 4 gm, 0.9% Sodium Chloride (USP) 100 mL). Volume: 108 mL. Single dose bag. For: Gaston Memorial Hospital By: Avella of Houston, 9256 Kirby Dr., Houston, TX 77054. NDC: 42852-905-10", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0936-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Fenton", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78678", "recalling_firm": "SSM Health Care St. Louis DBA SSM St. Clare Health Center", "address_1": "1015 Bowles Ave", "address_2": "N/A", "postal_code": "63026-2394", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "SSM Health entities in the state of MO only", "recall_number": "D-0144-2018", "product_description": "Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL, 10 mL syringe, Concentration: 100 mcg/mL.  This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-0104-01", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.", "recall_initiation_date": "20170810", "center_classification_date": "20171228", "termination_date": "20180322", "report_date": "20180103", "code_info": "Lot, exp: 170622-007, 9/20/2017; 170710-007, 10/8/2017"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0096-2019", "product_description": "Paliperidone Extended Release Tablets 3 mg, packaged in a) 30-count bottle(NDC 0591-3693-30), b) 90-count bottle (NDC-0591-3693-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054", "product_quantity": "27,816 bottles", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: a) 1220221A, Exp 03/2019; 1269627A, Exp 09/2019; 1274295A, Exp 10/2019; b) 1220222A, Exp 03/2019; 1270501A, Exp 09/2019; 1274296A, Exp 10/2019; 1288766A, Exp 01/2020"}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA204426"], "brand_name": ["TAYTULLA"], "generic_name": ["NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-5862"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["1421459", "1421460", "1421461", "1809905"], "spl_id": ["e8ec3b12-4ce1-4bdb-86e6-927469e011e4"], "spl_set_id": ["2fa8e8dc-f7b0-429a-b554-0e3c4291c92c"], "package_ndc": ["0023-5862-28", "0023-5862-30", "0023-5862-29", "0023-5862-31", "3002358622"], "is_original_packager": [true], "upc": ["300235862290"]}, "product_type": "Drugs", "event_id": "80136", "recalling_firm": "Allergan, PLC.", "address_1": "5 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0875-2018", "product_description": "Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale  Distributed by: Allergan USA INC Irvine, CA 92612    NDC 0023-5862-28 (Blister Card)  NDC 0023-5862-29 (Blister Carton)  NDC 0023-5862-31 (Outer carton)    UPC 300235862290", "product_quantity": "168,768 blister cards (4,725,504 softgel capsules)", "reason_for_recall": "Contraceptive Tablets Out of Sequence.", "recall_initiation_date": "20180524", "center_classification_date": "20180615", "termination_date": "20220519", "report_date": "20180620", "code_info": "Lot# 5620706, Exp. 05/19"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201504"], "brand_name": ["QUETIAPINE"], "generic_name": ["QUETIAPINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-242", "67877-249", "67877-250", "67877-245", "67877-246", "67877-247", "67877-248"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "rxcui": ["312743", "312744", "312745", "317174", "389201", "616483", "616487"], "spl_id": ["96978e8e-30c0-4844-a195-a42abd9615b4"], "spl_set_id": ["3112a006-1c61-47f2-84f5-9a7670d09c9b"], "package_ndc": ["67877-242-01", "67877-242-10", "67877-242-38", "67877-242-33", "67877-249-01", "67877-249-10", "67877-249-38", "67877-249-33", "67877-250-01", "67877-250-38", "67877-250-33", "67877-250-10", "67877-245-01", "67877-245-38", "67877-245-33", "67877-246-01", "67877-246-38", "67877-246-33", "67877-246-10", "67877-247-60", "67877-247-38", "67877-247-33", "67877-247-10", "67877-248-01", "67877-248-38", "67877-248-33", "67877-248-10"], "is_original_packager": [true], "unii": ["2S3PL1B6UJ"], "upc": ["367877248011"]}, "product_type": "Drugs", "event_id": "81568", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0287-2019", "product_description": "Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only,  Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC  67877-248-01, UPC code: 3 67877-248-01 1", "product_quantity": "N/A", "reason_for_recall": "Presence of Foreign Substance; metal shard found in tablet", "recall_initiation_date": "20181114", "center_classification_date": "20181128", "termination_date": "20200330", "report_date": "20181205", "code_info": "Lot 7143908, exp Nov 2020"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "40 bags", "code_info": "Lot #: 5/1/18 0511 515-74725P, BUD 7/30/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "HEPARIN 1,000 Units in NS 250mL. (Heparin Sodium, USP 1,000 Units, 0.9% Sodium Chloride, USP 250 mL) Volume: 251 mL. Single dose bag. For: Adventist Medical Center Hanford. By: Avella of Huston, 9265 Kirby Dr., Houston TX, 77054. NDC 42852-747-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0948-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0308-2018", "product_description": "Medline Incision and Drainage Tray, Sterile, Single Use Only. Packaged in Mexico by Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "808 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: MDS70815; Lots 16LB2959; 173B1289; 17HB4108; 17FB6679; 16JB8627  Pack Number: MDS70815H; Lots 17FB6679", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79955", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-0825-2018", "product_description": "Loxapine Capsules, USP  50 mg, Rx Only,  100-count bottles, NDC 0378-7050-01", "product_quantity": "11,650 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180424", "center_classification_date": "20180522", "termination_date": "20190814", "report_date": "20180530", "code_info": "NDC 0378-7050-01    Lot Numbers:  3079386, Exp. 10/31/18  3079387, Exp. 10/31/18  3079388, Exp. 10/31/18  3083762, Exp. 3/31/19  3083763, Exp. 3/31/19  3083764, Exp. 3/31/19  3083765, Exp. 3/31/19  3083766, Exp. 3/31/19  3083767, Exp. 3/31/19"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074984"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-014", "63739-015", "63739-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830837", "830845", "830861"], "spl_id": ["205ba6f0-3a28-153f-e063-6294a90ab9e2"], "spl_set_id": ["2ec2afa8-f91a-46cd-ac4e-b8ffa59015ec"], "package_ndc": ["63739-014-10", "63739-015-10", "63739-016-10"], "original_packager_product_ndc": ["10370-829", "10370-830", "10370-831"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "79936", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd Nw", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide with the US", "recall_number": "D-0714-2018", "product_description": "Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10", "product_quantity": "4266 cartons", "reason_for_recall": "Failed Dissolution Specifications. High dissolution results were obtained during stability testing.", "recall_initiation_date": "20180423", "center_classification_date": "20180507", "termination_date": "20201013", "report_date": "20180502", "code_info": "Lot #: 0115086, Exp. 12/2018"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0533-2018", "product_description": "Vardenafil HCl USP (trihydrate) for prescription compounding, packaged in a) 5g (NDC 58597-8575-2); b) 100g (NDC 58597-8575-6);c) 500g (NDC 58597-8575-7); d) 1000g (NDC 58597-8575-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "10000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 070717-2, Exp. 05/31/2020; b)  070717-1, Exp. 05/31/2020; c)  070717-1, Exp. 05/31/2020; d)  070717-1, Exp. 05/31/2020."}, {"country": "United States", "city": "Windsor", "address_1": "755 Rainbow Rd Ste B", "reason_for_recall": "Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.", "address_2": "", "product_quantity": "1,397 bags", "code_info": "Lot # 1218000677, 1218000947, 1218000982, 1218001018, 1218001029, 1218001059, 1218001060, 1218001078, 1218001079, 1218001171, 1218001172, 1218001192, 1218001193, 1218001207, 1218001209, 1218001210, Exp 06/19/2018-07/03/2018", "center_classification_date": "20180702", "distribution_pattern": "Product was distributed throughout the United States.", "state": "CT", "product_description": "Norepinephrine Bitartrate 16 mg (64 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT", "report_date": "20180711", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals, LLC", "recall_number": "D-0900-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80303", "termination_date": "20190204", "more_code_info": "", "recall_initiation_date": "20180614", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091363"], "brand_name": ["ZOLEDRONIC ACID"], "generic_name": ["ZOLEDRONIC ACID"], "manufacturer_name": ["Dr.Reddy's Laboratories Ltd"], "product_ndc": ["55111-688"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ZOLEDRONIC ACID"], "rxcui": ["705824"], "spl_id": ["251add88-5c4f-2750-c713-744fcf3a60ba"], "spl_set_id": ["f94a5c9e-74bc-d09e-cd65-394b2a5de2ad"], "package_ndc": ["55111-688-52"], "is_original_packager": [true], "upc": ["0355111688525"], "unii": ["6XC1PAD3KF"]}, "product_type": "Drugs", "event_id": "81012", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to retailers, distributors, physician officers and medical facilities throughout the United States.", "recall_number": "D-0103-2019", "product_description": "Zoledronic Acid Injection, 5mg/100 mL (0.05 mg/mL) 100ml vial, Rx Only. Mfd By: Gland Pharma Limited D.P. Pally - 500 043 India: Mfd. For: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India. NDC 55111-688-52", "product_quantity": "59,468 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS for unknown impurities.", "recall_initiation_date": "20180912", "center_classification_date": "20181026", "termination_date": "20200303", "report_date": "20181003", "code_info": "Batch Numbers: BS633, EXP 9/2018; BS701, BS702, BS703, EXP 12/2018; BS708, BS709, BS711, BS712, BS713, BS714, BS715, EXP 3/2019; BS726, BS727, EXP 6/2019; BS728, BS729, BS730, EXP 7/2019; BS801, EXP 03/2020..", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80915", "recalling_firm": "SCA Pharmaceuticals, Inc.", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Three hospitals in DC, VA, CT", "recall_number": "D-1189-2018", "product_description": "Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.", "product_quantity": "1384 bags", "reason_for_recall": "Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.", "recall_initiation_date": "20180827", "center_classification_date": "20180912", "termination_date": "20200602", "report_date": "20180919", "code_info": "Lots: 20180711@18, BUD: 10/3/2018; 20180712@19, 20180712@21, 20180712@24 BUD: 10/4/2018; 20180713@19, BUD: 10/5/2018; 20180727@21, BUD: 10/19/2018; 20180803@20, BUD: 10/26/2018"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0800-2018", "product_description": "Lupron Depot 22.5 mg 3 month Kit NDC 00074-3346-03 84 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065095"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["55289-866"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["35be2551-f5b2-1960-e063-6394a90abf4d"], "spl_set_id": ["c96d3986-9d92-4ec4-a319-a50aeb2f4fe7"], "package_ndc": ["55289-866-02", "55289-866-04", "55289-866-06", "55289-866-07", "55289-866-10", "55289-866-14", "55289-866-20", "55289-866-28", "55289-866-30", "55289-866-50", "55289-866-60", "55289-866-71", "55289-866-74", "55289-866-85", "55289-866-86", "55289-866-87", "55289-866-90", "55289-866-93", "55289-866-98", "55289-866-01", "55289-866-82", "55289-866-95"], "original_packager_product_ndc": ["0143-2112"], "upc": ["0355289866954"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "80791", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1127-2018", "product_description": "Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count bottles, NDC 55289-866-06; c) 7-count bottles, NDC 55289-866-07; d) 10-count bottles, NDC 55289-866-10; e) 14-count bottles, NDC 55289-866-14; f) 20-count bottles, NDC 55289-866-20; g) 28-count bottles, NDC 55289-866-28; h) 30-count bottles, NDC 55289-866-30; i) 120-count bottles, NDC 55289-866-98; j) 300-count bottles, NDC 55289-866-87; k) 400-count bottles, NDC 55289-866-74; Rx only, Packaged By PD-Rx Pharmaceuticals, Oklahoma City, OK  73127.", "product_quantity": "6,641 bottles", "reason_for_recall": "Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.", "recall_initiation_date": "20180807", "center_classification_date": "20180824", "termination_date": "20200507", "report_date": "20180905", "code_info": "Lot #: a) D17D29, L17C73, F18E73, Exp. 1/31/19; b) H17D70, K17F66, G18F26, Exp. 1/31/19; c) C18G26, F18E36, Exp. 1/31/19; d) F18A85, Exp. 1/31/19; e) K17B44, K17E29, L17D93, Exp. 1/31/19; E17B88, Exp. 5/31/19; H17A52, H17D67, Exp. 7/31/19; f) E17B01, E17E83, Exp. 5/31/19; F17C99, Exp. 6/30/19; G17C08, G17E18, H17B01, H17B66, H17F67, I17A56, Exp. 7/31/19; g) E17E27, Exp. 1/31/19, I17A33, G17D62, Exp. 7/31/19; h) E17B35, E17D90, Exp. 5/31/19, F17C13, Exp. 6/30/19, G17B25, H17C58, Exp. 7/31/19; i) G17D59, Exp. 7/31/19; j) I17A69, G17D58, Exp. 7/31/19; k) G17D56, Exp. 7/31/19."}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021908"], "brand_name": ["AMITIZA"], "generic_name": ["LUBIPROSTONE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["64764-080", "64764-240"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LUBIPROSTONE"], "rxcui": ["616578", "617768", "794639", "794641"], "spl_id": ["c2ca8178-4da1-42d1-a8b9-ff66dca82649"], "spl_set_id": ["d474ac6a-444d-4aa6-9986-24be6fcf811d"], "package_ndc": ["64764-080-60", "64764-080-40", "64764-240-60", "64764-240-10", "64764-240-40"], "is_original_packager": [true], "nui": ["N0000175573", "N0000175456"], "pharm_class_epc": ["Chloride Channel Activator [EPC]"], "pharm_class_moa": ["Chloride Channel Activators [MoA]"], "unii": ["7662KG2R6K"]}, "product_type": "Drugs", "event_id": "81518", "recalling_firm": "Takeda Development Center Americas, Inc.", "address_1": "1 Takeda Pkwy", "address_2": "4034BB1", "postal_code": "60015-5713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 32 distributors throughout the United States.", "recall_number": "D-0286-2019", "product_description": "AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Rockville MD 20850 and Takeda Pharmaceuticals America, Inc. Deerfield, IL 60015. Active Ingredient made in Japan, encapsulated in the United States.  NDC 64764-080-60", "product_quantity": "69,075 60-count bottles (4,144,500 capsules)", "reason_for_recall": "Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.", "recall_initiation_date": "20181106", "center_classification_date": "20181128", "termination_date": "20190620", "report_date": "20181121", "code_info": "Lot # 3098628-61, exp. date 02/28/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0455-2018", "product_description": "Lidocaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0197-2019", "product_description": "Trimix Alprostadil/ Phentolamine/Papavarin 40 mcg/1 mg/30 mg 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1330-05", "product_quantity": "65 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08062018:52 Discard by: 10/5/2018; 08012018:08 Discard by: 9/30/2018"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0114-2019", "product_description": "SleepEase, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879.NDC 61096-0001-1 and Tester NDC 6196-1001-1", "product_quantity": "5,393 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0272-2018", "product_description": "Medline DC Line Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "363 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDC1971; Lots: 175B1999;   Pack Number: DYNDC1971H; Lots: 17OB8570; 175B1999", "more_code_info": ""}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1089-2018", "product_description": "Acetylcysteine 10% Oph Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots with expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80980", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to hospitals in USA", "recall_number": "D-0003-2019", "product_description": "Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173, Bloombury, NJ 08804, UPC 70092103417.", "product_quantity": "528 bags", "reason_for_recall": "Subpotent Drug: Product may not have the active ingredient present in the bag.", "recall_initiation_date": "20180827", "center_classification_date": "20181001", "termination_date": "20190402", "report_date": "20180926", "code_info": "Lot #:30000271, Exp 10/1/18"}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79253", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, USA", "recall_number": "D-0547-2018", "product_description": "SyrSpend SF Suspending Base, a) 500 mL (NDC 51552-1079-5) and b) 4 L (NDC 51552-1079-9), Rx Only, Manufactured by Fagron Inc. St. Paul, MN 55120", "product_quantity": "a) 1007 bottles (500 mL) and b) 738 bottles (4 L)", "reason_for_recall": "Microbial contamination of Non-Sterile Product;  product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).", "recall_initiation_date": "20180214", "center_classification_date": "20180227", "termination_date": "20190910", "report_date": "20180307", "code_info": "a) 17I28-U80-039976, exp. 10/02/2020; b) 17I28-U80-039977, exp. 10/02/2020"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0207-2018", "product_description": "7-Keto DHEA 25mg Capsule, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "90 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 06082017@36 BUD: 12/5/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0522-2018", "product_description": "Sumatriptan USP for prescription compounding, packaged in 10g (NDC 58597-8089-3); b) 25g (NDC 58597-8089-4); c)100g (NDC 58597-8089-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "10000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) SUT1213030SP-11192014, Exp. 11/30/2018; b) SUT1213030SP-11192014, exp. 11/30/2018; c) SUT1213030SP-7222015, Exp.11/30/2018."}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0744-2018", "product_description": "Cayston 75 mg Inh. Soln. SDV NDC 61958-0901-01 56 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0192-2019", "product_description": "Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03", "product_quantity": "67 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05072018:35 Discard by: 11/3/2018; 06122018:01 Discard by: 12/9/2018"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "966 cases", "code_info": "Product Code: 6002; Lots: Product Code: 6002; Lots: 52149, EXP 08/04/2017; 52982, EXP 09/21/2017; 53942, 54042, EXP 01/19/2018;  54925, 54952, 54958, 54959, 54962, EXP 03/08/2018; 55872, EXP 04/25/2018; 57449, EXP 08/25/2018; 58381, EXP 09/14/2018; 59302, EXP 09/22/2018; 59765, EXP 11/22/2018; 61788, 61831 EXP 02/14/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Short Term Oral Swab System with Perox-A-Mint Solution.  Contains: 20 Individually wrapped Toothette Plus Oral Swabs with sodium bicarbonate,   1.5 fl.oz/44mL bottle of Perox-A-Mint solution and One (1) 0.5 oz/14g tube of Mouth Moisturizer,  Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6002 UPC (01)00618029820921", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0355-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "YANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0567-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79062", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide within the United States", "recall_number": "D-0541-2018", "product_description": "Fentanyl Transdermal System, 50 mcg/h, packaged in 5 pouch system cartons (NDC 0591-3212-72),  Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3212-54.", "product_quantity": "929,916 (5 pouches/carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits", "recall_initiation_date": "20180129", "center_classification_date": "20180222", "termination_date": "20180905", "report_date": "20180214", "code_info": "Lot #: 1103917A, Exp. Feb 2018; 1114192A, Exp. Apr 2018; 1125605A, Exp. Jun 2018; 1138897A, 1153171A, Exp. Aug 2018; 1156261A, Exp. Oct 2018;  1171595A, Exp. Nov 2018; 1179544A, Exp. Jan 2019; 1189531A, Exp. Mar 2019; 1211389A,Exp. May 2019; 1227468A, Exp. Jun 2019; 1231784A, 1232943A, Exp. Sep 2019."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202236"], "brand_name": ["DYMISTA"], "generic_name": ["AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["0037-0245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["AZELASTINE HYDROCHLORIDE", "FLUTICASONE PROPIONATE"], "rxcui": ["1797847", "1797849"], "spl_id": ["ed1f7ce9-ccfa-4e73-940f-14ea8166d524"], "spl_set_id": ["4c557ec4-c4cf-11df-851a-0800200c9a66"], "package_ndc": ["0037-0245-23"], "is_original_packager": [true], "unii": ["0L591QR10I", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "77850", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1075-2018", "product_description": "Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only,  Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23", "product_quantity": "20,780 bottles", "reason_for_recall": "Presence of foreign substance: Potential for glass in the neck area of the glass bottles.", "recall_initiation_date": "20180725", "center_classification_date": "20180809", "termination_date": "20190815", "report_date": "20180815", "code_info": "Lot #: GA70246, GA70254, Exp 02/2019"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1142-2018", "product_description": "Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 5 mg/160 mg/12.5 mg,  30 tablets per bottle, Rx Only, Manufactured by:  Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-326-30", "product_quantity": "50,784 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BBY1E001,  BBY1E003,  BBY1C002,  BBY1E002,  BBY1D001"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171116@3, BUD 05/15/2018; 20180221@72, BUD, 08/20/2018; 20171130@79, BUD 05/29/2018; 20180221@72, BUD 08/20/2018; 20180206@115, BUD 08/05/2018; 20171023@98, BUD 04/21/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Testosterone/Anastrozole 200 mg/20 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0670-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065095"], "brand_name": ["DOXYCYCLINE HYCLATE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-0430"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["6f5ebbca-b3a8-4bee-a3c3-1f211b98df88"], "spl_set_id": ["e7c14a8e-c713-4f03-94e8-1ec9ae077d4d"], "package_ndc": ["0904-0430-95", "0904-0430-04", "0904-0430-06"], "original_packager_product_ndc": ["0143-2112"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "80659", "recalling_firm": "MAJOR PHARMACEUTICALS", "address_1": "17177 N Laurel Park Dr", "address_2": "N/A", "postal_code": "48152-2693", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1026-2018", "product_description": "Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NY 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-0430-04", "product_quantity": "3,161 Cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20180730", "center_classification_date": "20180802", "termination_date": "20191202", "report_date": "20180808", "code_info": "Lot: 71545AA, exp 7/2019"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090866"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-5807", "0378-5813", "0378-5814", "0378-5815"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["a5384d58-48c7-494a-a8a8-c296b316bd91"], "spl_set_id": ["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"], "package_ndc": ["0378-5807-93", "0378-5813-77", "0378-5814-77", "0378-5815-77"], "is_original_packager": [true], "upc": ["0303785815778", "0303785813774", "0303785807933", "0303785814771"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0314-2019", "product_description": "Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77.", "product_quantity": "12,840 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3071352, exp. date 7/2019"}, {"status": "Terminated", "city": "Olive Branch", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81668", "recalling_firm": "Westminster Pharmaceuticals Llc", "address_1": "1 & 2", "address_2": "154 Downing Street", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0300-2019", "product_description": "Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-119-01; b) 90 count bottle NDC 69367-119-03", "product_quantity": "1571 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed traces of NDEA  impurity in specific lots of Irbesartan.", "recall_initiation_date": "20181029", "center_classification_date": "20181214", "termination_date": "20211026", "report_date": "20181219", "code_info": "Batch Numbers: a) B160002A Exp. 09/30/2019; b) B160002B Exp. 09/30/2019"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206674"], "brand_name": ["BUPROPION HYDROCHLORIDE (SR)"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Cipla USA Inc.,"], "product_ndc": ["69097-877", "69097-878", "69097-879"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["a9b85841-5a69-4df1-a22d-3d4cf174e9a6"], "spl_set_id": ["9d2c209b-248e-4e26-9cde-fe0abe4428c1"], "package_ndc": ["69097-877-02", "69097-877-03", "69097-877-07", "69097-877-12", "69097-878-02", "69097-878-03", "69097-878-07", "69097-878-12", "69097-879-02", "69097-879-03", "69097-879-07", "69097-879-12"], "is_original_packager": [true], "upc": ["0369097879037", "0369097878030", "0369097877033"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "79446", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "7 Oser Ave", "address_2": "N/A", "postal_code": "11788-3811", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0618-2018", "product_description": "buPROPion HCl Extended-Release Tablets,   USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03", "product_quantity": "N/A", "reason_for_recall": "Failed Dissolution Specifications; during stability testing", "recall_initiation_date": "20180315", "center_classification_date": "20180404", "termination_date": "20210915", "report_date": "20180411", "code_info": "Lot# I1606579 and Lot# I1606580 Exp: 05/2018; Lot# I1612114 and Lot# I1612115 Exp: 11/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0027-2019", "product_description": "DERMATONE (titanium oxide 6% and zinc oxide 4.7%) No-Touch Sunscreen Stick, SPF 50, Net Wt. 0.49 oz. (13.9g) stick, Distributed by: Beaumont Products, Inc. Kennesaw, GA 30144, UPC 0 20908 05100 3.", "product_quantity": "5025 sticks", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: sample tested positive for Staphylococcus aureus.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 172428G"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "849 cases", "code_info": "Product Code: 6002-D; Lots: 57942, EXP 09/08/2018; 58186, 58673, EXP 09/14/2018; 60297, EXP 12/19/2018; 61893, EXP 02/14/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Short Term Oral Care System with Perox-A-Mint solution, Contains 1.5 fl oz/44 ml bottle of Perox-A-Mint solution, 0.5 oz/14g tube of Mouth Moisturizer, 0.3 oz/9g tube of Sodium Bicarbonate Mouthpaste, 1 Ultra-Soft Toothbrush,  Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6002-D UPC (01)00618029821461", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0361-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Mahwah", "address_1": "750 Corporate Dr", "reason_for_recall": "CGMP Deviations: Market complaints related to \"gritty texture\".", "address_2": "", "product_quantity": "5136 tubes", "code_info": "Batch Number: 05170598; Exp. 03/19", "center_classification_date": "20180207", "distribution_pattern": "Product was distributed throughout the United States.", "state": "NJ", "product_description": "Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village  Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430  NDC 68462019255  UPC 3684620192559", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "recall_number": "D-0336-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78605", "termination_date": "20181003", "more_code_info": "", "recall_initiation_date": "20171120", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0162-2019", "product_description": "HCG 4000 Unit Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1704-01", "product_quantity": "2737 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03142018:73 Discard by: 3/9/2019; 04122018:64 Discard by: 4/7/2019; 07162018:84 Discard by: 7/11/2019; 06192018:36 Discard by: 6/12/2019; 08062018:28 Discard by: 8/1/2019"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80045", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to physicians and internet sales throughout the United States and Hong Kong, Panama, UK, China, Jordan, Qatar, Kuwait, and Central America.", "recall_number": "D-0833-2018", "product_description": "Zoma Shampoo, Zinc Pyrithione 1.92%, 300 ml/10.01 fl. oz. bottles, Dermatologic Cosmetic Laboratories, East Haven, CT", "product_quantity": "1,348 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20180504", "center_classification_date": "20180522", "termination_date": "20190318", "report_date": "20180530", "code_info": "Lot # HT659-6, expiration date 08/11/2019  LT168-7, expiration date 11/10/2019"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79501", "recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC", "address_1": "920 Winter St", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0827-2018", "product_description": "0.9% Sodium Chloride  Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10.", "product_quantity": "25,356 1 liter bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20171113", "center_classification_date": "20180522", "termination_date": "20181206", "report_date": "20180530", "code_info": "Lot # 17LU05005; Exp. 09/18  Part Number  060-10109"}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79969", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0826-2018", "product_description": "Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, Rx Only, Manufactured by: Cipla Ltd., India; For: EAGLE PHARMACEUTICALS, INC., Woodcliff Lake, NJ 07677 USA, NDC 42367-111-06.", "product_quantity": "5256 bottles", "reason_for_recall": "Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.", "recall_initiation_date": "20180420", "center_classification_date": "20180522", "termination_date": "20200604", "report_date": "20180530", "code_info": "Lot: GH70154, Exp 12/18"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80397", "recalling_firm": "Aidarex Pharmaceuticals LLC", "address_1": "595 N Smith Ave", "address_2": "N/A", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0990-2018", "product_description": "Enalapril Maleate, USP 2.5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India.  NDC: 33261-0977-90", "product_quantity": "11, 90-count bottles", "reason_for_recall": "Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.", "recall_initiation_date": "20180627", "center_classification_date": "20180725", "termination_date": "20191204", "report_date": "20180801", "code_info": "Lots: 56698-1, EXP 1/31/2019; 56698-2, EXP 4/30/2019"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0853-2018", "product_description": "Gericare Iron Supplement Elixir Ferrous Sulfate 220 mg, packaged in 16 fl oz. (473 mL) bottles, Dist by: Gericare Pharmaceuticals Corp. 1650 63rd Street  Brooklyn, NY 11204, NDC 57896-709-16, UPC 57896709167", "product_quantity": "8124 bottles", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 4780111, Exp. 08/19"}, {"status": "Ongoing", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81613", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0317-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A. NDC 0378-6325-05.", "product_quantity": "5,660 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.", "recall_initiation_date": "20181120", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot # 3084886, exp. date 2/2019     Lot # 3093804, exp. date 12/2019"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0773-2018", "product_description": "Revlimid 20 mg oral cap NDC 59572-0420-21 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0195-2018", "product_description": "Sermorelin, 3 mg/ GHRP6, 3 mg/GHRP2, 3 mg, Vial - Lyophilized, For SC Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "597 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 06162017@12 BUD: 12/13/2017; 08042017@1 BUD: 1/31/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0777-2018", "product_description": "Ibrance 125 mg cap NDC 00069-0189-21 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA200740"], "brand_name": ["CYSTARAN"], "generic_name": ["CYSTEAMINE HYDROCHLORIDE"], "manufacturer_name": ["Leadiant Biosciences, Inc."], "product_ndc": ["54482-020", "54482-035"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CYSTEAMINE HYDROCHLORIDE"], "rxcui": ["1313780", "1313785"], "spl_id": ["0ae95603-411c-455b-8bb8-8c5b01dac297"], "spl_set_id": ["b98ee838-ed23-42a9-93b5-72579e490fba"], "package_ndc": ["54482-020-01", "54482-020-02", "54482-035-02"], "is_original_packager": [true], "unii": ["IF1B771SVB"]}, "product_type": "Drugs", "event_id": "79849", "recalling_firm": "LEADIANT BIOSCIENCES, INC", "address_1": "9841 Washingtonian Blvd Ste 500", "address_2": "", "postal_code": "20878-7352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Walgreens Specialty Pharmacy Pittsburg, PA  Italy and Germany", "recall_number": "D-0683-2018", "product_description": "Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co. Inc. Amityville, NY 11701 for Leadiant Biosciences, Inc. Gaithersburg, MD 20878, NDC 54482-020-01", "product_quantity": "3,398 bottles", "reason_for_recall": "Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.", "recall_initiation_date": "20180409", "center_classification_date": "20180417", "termination_date": "20181129", "report_date": "20180425", "code_info": "lot numbers: 35866, Exp 6/18; 358663, Exp 7/18", "more_code_info": ""}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80638", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-1043-2018", "product_description": "10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 100 mL in 150 mL Intravia Bag, PharMEDium Services, LLC.", "product_quantity": "230 Intravia Bags", "reason_for_recall": "CGMP deviations: Product was released while a hood certification discrepancy was being investigated.", "recall_initiation_date": "20180724", "center_classification_date": "20180803", "termination_date": "20181210", "report_date": "20180815", "code_info": "Lot 181760013D, 181730007D, Exp 08/09/2018, 09/02/2018"}, {"status": "Terminated", "city": "Hasbrouck Heights", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079163"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-138", "29300-139", "29300-140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099625", "1099678", "1099870"], "spl_id": ["674e58bd-f580-4805-a7e2-febcaa37bca5"], "spl_set_id": ["1ec1a441-218a-4c80-a0cb-69bcc327f472"], "package_ndc": ["29300-138-01", "29300-138-05", "29300-138-10", "29300-139-01", "29300-139-05", "29300-139-10", "29300-140-01", "29300-140-05", "29300-140-10"], "is_original_packager": [true], "upc": ["0329300140019"], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "78786", "recalling_firm": "Unichem Pharmaceuticals Usa Inc", "address_1": "777 Terrace Ave", "address_2": "Suite 102", "postal_code": "07604-3102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA.", "recall_number": "D-0228-2018", "product_description": "Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd. Ind. Area, Meerut Road, Ghaziabad-201 003, India. Marketed By: Unichem Pharmaceuticals (USA), Inc. Hasbrouck Heights, NJ 07604. NDC 29300-140-01", "product_quantity": "96,876 Bottles of 30\u0019s", "reason_for_recall": "Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.", "recall_initiation_date": "20171219", "center_classification_date": "20180117", "termination_date": "20180912", "report_date": "20180124", "code_info": "Lot: ZDPH17040"}, {"status": "Ongoing", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204821"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-367", "43547-368", "43547-369", "43547-370"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["c540c941-b8fc-4a32-bfa7-00fba4ca9dcf"], "spl_set_id": ["26080940-bcd3-446d-9026-3ddfb58e281e"], "package_ndc": ["43547-367-03", "43547-367-09", "43547-367-50", "43547-367-11", "43547-368-03", "43547-368-09", "43547-368-50", "43547-368-11", "43547-369-03", "43547-369-09", "43547-369-50", "43547-369-11", "43547-370-03", "43547-370-09", "43547-370-50", "43547-370-11"], "is_original_packager": [true], "upc": ["0343547370039", "0343547369033", "0343547368036", "0343547367039"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "80525", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "2002 Eastpark Blvd", "address_2": "N/A", "postal_code": "08512-3514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States", "recall_number": "D-0970-2018", "product_description": "Solco Healthcare US Valsartan, USP, 160 MG Tablets, 90-count bottles, Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd.  Xynqiao, Linhai, Zhejiang 317024, China  Distributed by:  Solco Healthcare US, LLC  Cranbury, NJ 08512 USA   NDC 43547-369-09", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180713", "center_classification_date": "20180720", "report_date": "20180801", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80006", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Recalling firm distributed product to wholesalers throughout the United States, including Puerto Rico.", "recall_number": "D-0829-2018", "product_description": "PrednisoLONE Sodium Phosphate Orally Disintegrating Tablets 10 mg, Rx Only, 48-count bottle, NDC 00378-4710-22", "product_quantity": "7,334 48-count bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180430", "center_classification_date": "20180522", "termination_date": "20190214", "report_date": "20180530", "code_info": "Lot #:  3081542, Exp. 08/18   3081543, Exp. 08/18   3081544, Exp. 08/18   3082235, Exp. 08/18   3085903, Exp. 12/18  3088974, Exp. 06/19  3090445, Exp. 06/19"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0504-2018", "product_description": "Levofloxacin Hemihydrate USP for prescription compounding, packaged in a) 100g (NDC 58597-8085-6); b) 1000g (NDC 58597-8085-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "10000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 072915-1, Exp. 07/05/2019; b) 072915-1, Exp. 07/05/2019"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C230 BUD: 11/1/2018; C233 BUD: 11/3/2018; C234 BUD: 11/9/2018; C237 BUD: 11/13/2018; C240 BUD: 11/15/2018; C242 BUD: 11/20/2018; C244 BUD: 11/27/2018; C248 BUD: 12/4/2018; C250 BUD: 12/6/2018; C252 BUD: 12/12/2018; C256 BUD: 12/14/2018; C258 BUD: 12/18/2018; C264 BUD: 12/27/2018; D006 BUD: 1/8/2019; D009 BUD: 1/10/2019; D013 BUD: 1/15/2019; D015 BUD: 1/17/2019; D019 BUD: 1/22/2019; D024 BUD: 1/29/2019; D028 BUD: 2/1/2019; D034 BUD: 2/8/2019; D041 BUD: 2/20/2019; D059 BUD: 3/13/2019; D063 BUD: 3/15/2019; D070 BUD: 3/26/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Testosterone 200mg pellet, 1 count (NDC 69761-120-01), 6 count (NDC 69761-120-06), 12 count (NDC 69761-120-12), and 30 count (NDC 69761-120-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0233-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0268-2018", "product_description": "Medline I&D Tray Kit, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "40 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDA1109; Lots: 178B0923", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0479-2018", "product_description": "Clindamycin Phosphate USP for prescription compounding, packaged in a) 10g (NDC 58597-8198-3); b) 100g (NDC 58597-8198-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "1300 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 042315-1, Exp. 03/12/2018; b)  042315-1, Exp. 03/12/2018"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81028", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0010-2019", "product_description": "Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2", "product_quantity": "7777 bottles", "reason_for_recall": "CGMP Deviations; rejected product was used to manufacture final bulk lot", "recall_initiation_date": "20180920", "center_classification_date": "20181009", "termination_date": "20200508", "report_date": "20181017", "code_info": "Lot: T71137 Exp. Feb. 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Waukon", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80963", "recalling_firm": "Beaumont Bio-med, Inc.", "address_1": "21 1st Ave NE", "address_2": "N/A", "postal_code": "52172-1705", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1199-2018", "product_description": "Arthritis Pain Relief Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172; NDC 58066-7042-7", "product_quantity": "140 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20180831", "center_classification_date": "20180917", "termination_date": "20220916", "report_date": "20180926", "code_info": "Lot: 012916E, Exp 01/2019"}, {"status": "Terminated", "city": "Orange", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80701", "recalling_firm": "NuCare Pharmaceuticals Inc", "address_1": "622 W Katella Ave", "address_2": "N/A", "postal_code": "92867-4608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to three customers in Fl and CA", "recall_number": "D-1037-2018", "product_description": "Valsartan/HCTZ 160/12.5 mg Tablets, 90-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867, NDC 68071-4311-9", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180730", "center_classification_date": "20180803", "termination_date": "20210422", "report_date": "20180815", "code_info": "Lot # U01779; Exp. 04/30/2019"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81644", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA only", "recall_number": "D-0295-2019", "product_description": "Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma 1075 West Park One Drive Suite 100 Sugar Land, TX 77478. Product Code 70092-9035-05", "product_quantity": "168 bags", "reason_for_recall": "Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride", "recall_initiation_date": "20181121", "center_classification_date": "20181212", "termination_date": "20190501", "report_date": "20181219", "code_info": "Lot #:10016014 Exp. 01/06/2019"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0312-2018", "product_description": "Medline Suture Removal Pack Latex Safe, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "663 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: P734457; Lots 17GB5158; 17RB8681; 17FB0926", "more_code_info": ""}, {"status": "Terminated", "city": "Hallandale Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80699", "recalling_firm": "Pharmcore Inc.", "address_1": "1109 E Hallandale Beach Blvd", "address_2": "N/A", "postal_code": "33009-4431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1147-2018", "product_description": "Human Chorionic Gonadotropin 5000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009", "product_quantity": "5718 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20180802", "center_classification_date": "20180828", "termination_date": "20220118", "report_date": "20180905", "code_info": "Lots: HCG50319 Exp. 4/30/2019; HCG50316 Exp. 3/31/2019; HCG50317 Exp. 4/30/2019; HCG50315 Exp. 3/31/2019; HCG50318 Exp. 4/30/2019; HCG50320 Exp. 4/30/2019; HCG50321 Exp. 4/30/2019; HCG50311 Exp. 3/31/2019; HCG50310 Exp. 3/31/2019; HCG50309 Exp. 3/31/2019; HCG50313 Exp. 3/31/2019; HCG50314 Exp. 3/31/2019;"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0789-2018", "product_description": "Imatinib Mesylate Tablet 400 mg NDC 60505-2901-03 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0175-2018", "product_description": "Human Chorionic Gonadotropin 5,000 iu/ Vial Lyophilized, For SC Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "6,414 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 06132017@2 BUD: 12/10/2017; 07262017@17 BUD: 1/22/2018; 10032017@1 BUD: 4/1/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0525-2018", "product_description": "Testosterone (Soy) (Micronized) USP for prescription compounding, packaged in a) 25g (NDC 58597-0077-4); b) 100g (NDC 58597-0077-6), c) 500g (NDC 58597-0077-7); d)1000g (NDC 58597-0077-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "33000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 071516-3, Exp. 04/01/2019; b) 071516-3, Exp. 4/1/2019; c) 071516-1, 071516-2, Exp. 04/01/2019; d) 071516-1, 071516-3, Exp. 04/01/2019, 032117B-1, Exp. 2/9/2020."}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1140-2018", "product_description": "Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30 tablets per bottle, Rx Only, Manufactured by:  Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-207-30", "product_quantity": "78144 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BV53D004,  BV53C006,  BV53D001,  BV53D002,  BV53D003,  BV53C004,  BV53C005"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0527-2018", "product_description": "Testosterone Enanthate USP for prescription compounding, packaged in a) 25g (NDC 58597-0079-4); b) 100g (NDC 58597-0079-6); c) 500g (NDC 58597-0079-7); d) 1000g (NDC 58597-0079-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "47500 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 042016-2, Exp. 4/6/2019; b) 041217-1, Exp. 02/09/2019; 042016-2, 042016-3, Exp. 4/6/2019; c) 041217-1,  041217-3, Exp. 02/09/2019; 042016-1, Exp. 04/06/2019; 042016-2, Exp. 4/6/2019; d) 041217-3, Exp. 01/09/2019; 042016-1, Exp. 4/6/2019."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80000", "recalling_firm": "Vitalab Pharmacy, Inc", "address_1": "4045 E Bell Rd Ste 163", "address_2": "N/A", "postal_code": "85032-2240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled product was distributed to patients throughout the United States.", "recall_number": "D-0730-2018", "product_description": "Papaverine 9mg/Phentolamine 1mg/Atropine 0.1mg/Prostaglandinl 10mcg/ml, sterile injectable, Vitalab Pharmacy, Inc", "product_quantity": "22 vials", "reason_for_recall": "Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.", "recall_initiation_date": "20180424", "center_classification_date": "20180509", "termination_date": "20200123", "report_date": "20180516", "code_info": "Lot #: 03092018@52, 02122018@76, Exp 05/13/2018-06/07/2018"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0445-2018", "product_description": "Phenylephrine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Windsor", "address_1": "755 Rainbow Rd Ste B", "reason_for_recall": "Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.", "address_2": "", "product_quantity": "", "code_info": "Lot # 20180329@2, Exp 06/27/2018", "center_classification_date": "20180702", "distribution_pattern": "Product was distributed throughout the United States.", "state": "CT", "product_description": "Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag (200 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT", "report_date": "20180711", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals, LLC", "recall_number": "D-0904-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80303", "termination_date": "20190204", "more_code_info": "", "recall_initiation_date": "20180614", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80951", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1205-2018", "product_description": "MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only.  Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03", "product_quantity": "89,722 blister pack", "reason_for_recall": "Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.", "recall_initiation_date": "20180827", "center_classification_date": "20180921", "termination_date": "20191008", "report_date": "20180926", "code_info": "Lot # 17P0078, exp. date 12/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0153-2019", "product_description": "Glutamine 10 mg/mL Solution, Pharm D Solutions, Houston, Texas ---- NDC 69699-1439-59", "product_quantity": "1095 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 01402018:93 Discard by: 10/10/2018; 07122018:16 Discard by: 9/10/2018; 08302018:65 Discard by:"}, {"status": "Terminated", "city": "Grand Rapids", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80893", "recalling_firm": "Hellolife", "address_1": "4460 44th St SE Ste C600", "address_2": "N/A", "postal_code": "49512-4150", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Algeria  Australia  Belgium  Brazil  Bulgaria  Canada  Colombia  Croatia  Cyprus  Czech Republic  Denmark  Dominican Republic  Ecuador  Estonia  French Polynesia  Greece  Guadeloupe  Guam  Hong Kong  Hungary  India  Ireland  Israel  Italy  Latvia  Lithuania  Martinique  Mexico  Monaco  Netherlands  New Zealand  Norway  Peru  Poland  Portugal  Romania  Russia  Russian Federation  Saudi Arabia  Senegal  Serbia  Slovakia  Slovakia (Slovak Republic)  Slovenia  Swaziland  Sweden  Switzerland  Taiwan  Turkey  United Kingdom", "recall_number": "D-1201-2018", "product_description": "Neuroveen, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512.  NDC: 49726-015-02", "product_quantity": "4,358 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia", "recall_initiation_date": "20180823", "center_classification_date": "20180917", "termination_date": "20210127", "report_date": "20180919", "code_info": "Lot: NV/030717D, exp 7/2019"}, {"status": "Ongoing", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["ANDA202843"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST SODIUM"], "rxcui": ["200224"], "spl_id": ["30387eb8-222d-146e-e063-6294a90a12a7"], "spl_set_id": ["97a682c2-7e00-4d07-a5ac-4436c977f842"], "package_ndc": ["31722-726-30", "31722-726-90", "31722-726-01", "31722-726-10", "31722-726-31", "31722-726-32"], "is_original_packager": [true], "upc": ["0331722726306"], "unii": ["U1O3J18SFL"]}, "product_type": "Drugs", "event_id": "80803", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0081-2019", "product_description": "Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manfuactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, NDC 31722-726-30", "product_quantity": "98016 bottles", "reason_for_recall": "Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.", "recall_initiation_date": "20180815", "center_classification_date": "20181017", "report_date": "20181003", "code_info": "Lot #: MON17384, Exp 12/19", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0149-2019", "product_description": "Calcium Gluconate 2.5% a) 250 mL 25 mg/mL NDC 69699-0908-25; b) Nasal Spray 2.5 Inhal Soln. NDC 69699-0908-10; c) Nebulization Solution 2.5% Inhal. Soln NDC 69699-0908-10; d) Nebulization 250 mL 2.5% Inhal Soln NDC 69699-0908-25; e) Oral Spray 2.5% 2.5% Oral Soln NDC 69699-0917-60, Pharm D Solutions, Houston, Texas", "product_quantity": "57 bottles; 2300 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: a) 05072018:40 Discard by: 5/2/2019; b) 07262018:44 Discard by: 1/22/2019; c) 07122018:83 Discard by: 7/12/2019; d) 07262018:93 Discard by: 1/22/2019; e) 07262018:81 Discard by: 1/21/2019"}, {"status": "Completed", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA203311"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-745", "31722-746", "31722-747", "31722-748"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["2b44fd7a-fd5a-984d-e063-6294a90a3fff"], "spl_set_id": ["0ff36e83-b307-42db-a2ab-bae3f6805c20"], "package_ndc": ["31722-745-30", "31722-745-90", "31722-745-05", "31722-745-31", "31722-745-32", "31722-746-30", "31722-746-90", "31722-746-05", "31722-746-31", "31722-746-32", "31722-747-30", "31722-747-90", "31722-747-05", "31722-747-31", "31722-747-32", "31722-748-30", "31722-748-90", "31722-748-05", "31722-748-31", "31722-748-32", "3317227489"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"], "upc": ["331722748902"]}, "product_type": "Drugs", "event_id": "80773", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1116-2018", "product_description": "Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only   Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854   By: Hetero Hetero Labs Limited Unit V, Pollepally  Jadcherla Mahaboob Nagar - 509-301 India.     NDC 31722-748-90  UPC 331722748902", "product_quantity": "441,408 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180808", "center_classification_date": "20180823", "report_date": "20180829", "code_info": "All Lots with expiration dates 7/2018 to 6/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0207-2019", "product_description": "Trimix T-101 Alprostadil/Phapaverine/Phentolamine 5.9 mcg/17.65 mg/Phentolamine 0.59 mcg per mL Pharm D Solutions, Houston, Texas --- NDC 69699-1366-05", "product_quantity": "10 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 07242018:35 Discard by: 8/23/2018"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078720"], "brand_name": ["AMANTADINE HCL"], "generic_name": ["AMANTADINE HYDROCHLORIDE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMANTADINE HYDROCHLORIDE"], "rxcui": ["849389"], "spl_id": ["38566e1f-b7b1-540f-e063-6394a90a2760"], "spl_set_id": ["461e6444-189e-62ed-6c61-1c36a04459c6"], "package_ndc": ["50268-069-11", "50268-069-15"], "original_packager_product_ndc": ["69452-142"], "unii": ["M6Q1EO9TD0"]}, "product_type": "Drugs", "event_id": "79680", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0633-2018", "product_description": "Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15", "product_quantity": "2135 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20180330", "center_classification_date": "20180417", "termination_date": "20200604", "report_date": "20180425", "code_info": "Lot: 16719 Exp. 07/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0718-2018", "product_description": "ADENO-PLEX Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "200 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lot: AP/011218 Discard by 7/11/2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0063-2019", "product_description": "Walgreens, NO DRIP, Anefrin Nasal Spray (Oxymetazoline HCl 0.05%), Nasal Decongestant, Original, 12 Hour, Maximum Strength, 0.5 FL OZ (15 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015,NDC 0363-7005-01, UPC 3 11917 18537 8.", "product_quantity": "355,056 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0199-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/10 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1365-10", "product_quantity": "715 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:02 Discard by: 9/24/2018; 05302018:54 Discard by: 11/26/2018; 06062018:79 Discard by: 12/3/2018; 06122018:31 Discard by: 11/17/2018; 07252018:44 Discard by: 1/21/2019"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0784-2018", "product_description": "Sprycel 100 mg tablet NDC 00003-0852-22 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80000", "recalling_firm": "Vitalab Pharmacy, Inc", "address_1": "4045 E Bell Rd Ste 163", "address_2": "N/A", "postal_code": "85032-2240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled product was distributed to patients throughout the United States.", "recall_number": "D-0733-2018", "product_description": "Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL,  Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL,  Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc", "product_quantity": "60 vials", "reason_for_recall": "Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.", "recall_initiation_date": "20180424", "center_classification_date": "20180509", "termination_date": "20200123", "report_date": "20180516", "code_info": "Lot #:T101 03062018@69, 02052018@56, T104 03122018@62, 02072018@95, T105 03122018@63, 02072018@96, T106 03122018@64, 02072018@97, Exp 06/04/2018-06/10/2018"}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "cGMP deviations", "address_2": "", "product_quantity": "72 bags", "code_info": "Lot: 180660057S Exp. 6/5/2018", "center_classification_date": "20180417", "distribution_pattern": "MA, WA", "state": "IL", "product_description": "Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL), Rx only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478", "report_date": "20180425", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0632-2018", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "79799", "termination_date": "20200114", "more_code_info": "", "recall_initiation_date": "20180410", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0170-2019", "product_description": "Phenol 5% and Glycerin Aqueous Solution 10 mL Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1431-10", "product_quantity": "1139 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05082018:59 Discard by: 11/4/2018; 08082018:57 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0118-2019", "product_description": "Snore Soother, Homeopathic Oral Spray, 1.38 fl. oz (41ml), Manufactured for Sprayology Gaithersburg. MD 20879. NDC 61096-0024-1", "product_quantity": "1,055 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0457-2018", "product_description": "HYDROmorphone HCl in 5% Dextrose in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0491-2018", "product_description": "Estrone USP for prescription compounding, packaged in a)  5 g (NDC 58597-8049-3); b) 100mg (NDC 58597-8049-1); c) 25 g (NDC 58597-8049-4), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "5000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 052915-2, Exp. 05/05/2017; b) 052915-2, Exp. 05/05/2017;   c) 052915-1, Exp. 05/05/2017."}, {"status": "Terminated", "city": "Freiburg im Breisgau", "state": "N/A", "country": "Germany", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78682", "recalling_firm": "Pfizer Manufacturing Deutschland GmbH", "address_1": "Pfizer GmbH Arzneimittelwerk Godecke", "address_2": "(Betriebsstatte Freiburg)", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Germany; products were packaged at the Pfizer Manufacturing Deutshland Gmbh location and then distributed to other countries.  No product distributed in the United States or its territories.", "recall_number": "D-0212-2018", "product_description": "FOR EXPORT ONLY Atorvastatin calcium Film-Coated Tablets a) 80 mg SMT Tabs Bulk, b) 40 mg SMT G EP PR KR, c) 20 mg SMT G EP PR, d) 20 mg SMT G EP PR KR, FOR MANUFACTURING, PROCESSING OR REPACKAGING", "product_quantity": "a)7387263 tablets; b)5877188 tablets; c)11755825 tablets; d) 5872816 tablets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20170927", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Bulk Product Batch # ( Packaged Lot#) a)  S55350 Exp. 20 APR 2018, S55378 Exp. 07 MAR 2018, S55386 Exp. 14 MAR 2018, S53284 Exp.14 FEB 2018, S53283 Exp. 10 FEB 2018; b) S53287 Exp. 16 FEB 2018, S33417 Exp. 03 FEB 2018; c) S33445 Exp. 17 FEB 2018, S33452 Exp. 24 FEB 2018; d) S33397 Exp. 07 FEB 2018", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "a) Lot#: 20180219@88, 20180208@19, 20180219@45, BUD 08/18/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Estradiol 12.5 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0674-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Princeton", "address_1": "100 College Rd W", "reason_for_recall": "Cross Contamination with Other Products", "address_2": "", "product_quantity": "5100 bottles", "code_info": "Lot #: JA3077, Exp. 05/2021", "center_classification_date": "20181120", "distribution_pattern": "Nationwide within the United States", "state": "NJ", "product_description": "Isosorbide Dinitrate Tablets, USP 10 mg,100-count bottles, Rx Only Manufactured by: Sandoz Inc., Princeton, NJ 08540 For BluePoint Laboratories, NDC 68001-225-00", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Sandoz Inc", "recall_number": "D-0260-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81457", "termination_date": "20201002", "more_code_info": "", "recall_initiation_date": "20181102", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80365", "recalling_firm": "World Organix, LLC", "address_1": "6149 S. Rainbow Blvd #5", "address_2": "N/A", "postal_code": "89118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1126-2018", "product_description": "Blissful Remedies Kratom+CBD CBD infused Maeng Da, capsules 50-count packaged in While Foil Pouch.  Dist. by World Organix LLC, Las Vegas Nevada UPC# 7 11583 27057 4", "product_quantity": "553 50-count pouch, 27,650 capsules", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.", "recall_initiation_date": "20180626", "center_classification_date": "20180823", "termination_date": "20240930", "report_date": "20180815", "code_info": "Lot Code: 112710 Exp 03/2019"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0262-2018", "product_description": "Medline Trunk Kit, Non-sterile. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "231 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYKTRUNK1; Lots: 17FA0227;  17FA0470;  17FA1431;  17HA0258;  17HA0259", "more_code_info": ""}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0722-2018", "product_description": "LIPO-DEN EXTREME Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "3733 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lots: LE/101917 Discard by 4/17/2018; LE/110317 Discard by 5/2/2018; LE/110917 Discard by 5/8/2018; LE/010318 Discard by 7/2/2018; LE/012218 Discard by 7/21/2018; LE/020918 Discard by 8/8/2017"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20180219@31, BUD  04/02/2018; 20180212@42, 20180206@12, BUD 03/29/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "TM (ALP 50/PAPAV 30/PHENT1.5 mg), 3 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0660-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]